With their high tolerability and minimal side effects, peptides are transforming the way we approach chronic disease management, providing hope for patients who have long struggled with persistent symptoms and limited treatment options
Iebba V, Totino V, Gagliardi A, Santangelo F, Cacciotti F, Trancassini M, Mancini C, Cicerone C, Corazziari E, Pantanella F, Schippa S (2016) Eubiosis and dysbiosis: the two sides of the microbiota
All clinical trial data, research findings, and scientific information presented on this page are sourced from peer-reviewed academic publications
BMC Gastroenterology, [online] 17
The signs and symptoms of B12 deficiency differ widely